Arcadia Biosciences (RKDA) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to -$5.9 million.
- Arcadia Biosciences' Enterprise Value rose 1234.73% to -$5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.9 million, marking a year-over-year increase of 1234.73%. This contributed to the annual value of -$4.2 million for FY2024, which is 6398.98% up from last year.
- Latest data reveals that Arcadia Biosciences reported Enterprise Value of -$5.9 million as of Q3 2025, which was up 1234.73% from -$4.5 million recorded in Q2 2025.
- In the past 5 years, Arcadia Biosciences' Enterprise Value ranged from a high of -$3.2 million in Q1 2025 and a low of -$50.7 million during Q1 2021
- Its 5-year average for Enterprise Value is -$18.8 million, with a median of -$18.7 million in 2023.
- Per our database at Business Quant, Arcadia Biosciences' Enterprise Value plummeted by 27079.86% in 2021 and then skyrocketed by 6398.98% in 2024.
- Quarter analysis of 5 years shows Arcadia Biosciences' Enterprise Value stood at -$28.6 million in 2021, then rose by 27.31% to -$20.8 million in 2022, then skyrocketed by 43.3% to -$11.8 million in 2023, then surged by 63.99% to -$4.2 million in 2024, then crashed by 38.73% to -$5.9 million in 2025.
- Its last three reported values are -$5.9 million in Q3 2025, -$4.5 million for Q2 2025, and -$3.2 million during Q1 2025.